Skip to search formSkip to main contentSkip to account menu

LY 282122

Known as: LY 282,122, LY-282122, LY-282,122 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Xanomeline is a muscarinic receptor agonist currently in phase II clinical trials for the treatment of Alzheimer's disease. A…